Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRELUDE: Pramipexole Dose Finding in RLS
NCT00239486Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2002
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pramipexole in restless legs syndrome (RLS), sponsored by Boehringer Ingelheim. Started Oct 2002; status: completed.
02
Drugs
pramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00239486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00239486.